Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07478393 · ClinicalTrials.gov registry record · NA
Readiness and Progress in Emotion Regulation Therapy
A NA study of Depression and Anxiety, sponsored by Teachers College, Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT07478393: Recruiting NA study of Depression and Anxiety, sponsored by Teachers College, Columbia University.
NCT07478393 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Teachers College, Columbia University. The registered enrollment target is 36 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07478393, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Teachers College, Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is an open trial designed to examine individual changes that occur before, during, and after 6 modules of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.
Primary Outcome
The Attentional Control Scale (ACS) is a 21-item measure used to measure difficulties with concentration associated with problems regulating emotions. The focusing and shifting subscales of the ACS align with the two attention emotion regulation (ER) skills taught in ERT.
Conditions Studied
Interventions
- BEHAVIORAL Emotion Regulation Therapy via Telehealth
Study Locations (1)
New York
- Teachers College, Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-10-24 |
| Est. Completion | 2028-09-01 |
| Phase | NA |
What NCT07478393 shows while recruiting
NCT07478393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower).
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Emotion Regulation Therapy via Telehealth is the first listed.
NCT07478393 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07478393 about?
NCT07478393 is a clinical study titled "Readiness and Progress in Emotion Regulation Therapy". This study is an open trial designed to examine individual changes that occur before, during, and after 6 modules of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.
What is the current status of trial NCT07478393?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-10-24. Estimated completion is 2028-09-01.
What conditions does trial NCT07478393 study?
This clinical trial studies the following conditions: Depression, Anxiety, Distress, Emotional, Rumination, Worry.
What interventions are being tested in trial NCT07478393?
The interventions under investigation include: Emotion Regulation Therapy via Telehealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT07478393?
This trial is sponsored by Teachers College, Columbia University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07478393 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07478393's enrollment target sits among peer trials
36 538th of 679 higher than 140 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy